Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 6/20 | 0.46 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.45 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19851718 | 0.85 | HRH4 (0.46) | HRH3HRH4 | |
| SCHEMBL7781926 | 0.79 | CYP3A4 (0.56) | CYP3A4SLC7A5HRH3HRH4 | |
| SCHEMBL7779386 | 0.79 | CYP3A4 (0.56) | CYP3A4SLC7A5HRH3HRH4 | |
| SCHEMBL7780217 | 0.79 | CYP3A4 (0.56) | CYP3A4SLC7A5HRH3HRH4 | |
| SCHEMBL28032325 | 0.78 | CYP3A4 (0.55) | CYP3A4SLC7A5HRH3HRH4 | |
| SCHEMBL28221698 | 0.78 | CYP3A4 (0.55) | CYP3A4SLC7A5HRH3HRH4 | |
| SCHEMBL28031774 | 0.78 | CYP3A4 (0.55) | CYP3A4SLC7A5HRH3HRH4 | |
| SCHEMBL15228060 | 0.78 | CYP3A4 (0.57) | CYP3A4SLC7A5HRH3HRH4 | |
| SCHEMBL18878684 | 0.77 | NLN (0.48) | — | |
| SCHEMBL16381379 | 0.77 | TLR2 (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3493814-A1 | LIPID-SUBSTITUTED AMINO 1,2-AND 1,3-DIOL COMPOUNDS AS MODULATORS OF TLR2 DIMERIZATION | Neuropore Therapies, Inc. (US) | 2019-06-12 | — | — | EP | claimed |
| WO-2018026866-A1 | LIPID-SUBSTITUTED AMINO 1,2-AND 1,3-DIOL COMPOUNDS AS MODULATORS OF TLR2 DIMERIZATION | NEUROPORE THERAPIES, INC. (US) | 2018-02-08 | — | — | WO | claimed |
| WO-2018026866-A1 | LIPID-SUBSTITUTED AMINO 1,2-AND 1,3-DIOL COMPOUNDS AS MODULATORS OF TLR2 DIMERIZATION | NEUROPORE THERAPIES, INC. (US) | 2018-02-08 | — | — | WO | disclosed |